CAVA GROUP, INC.·4

Jun 18, 5:00 PM ET

KOCHEVAR KAREN 4

4 · CAVA GROUP, INC. · Filed Jun 18, 2024

Insider Transaction Report

Form 4
Period: 2024-06-17
Transactions
  • Sale

    Common Stock

    2024-06-17$92.41/sh5,625$519,8060 total
  • Sale

    Common Stock

    2024-06-17$93.25/sh3,750$349,6880 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2024-06-171,8755,625 total
    Exercise: $9.58Exp: 2033-01-24Common Stock (1,875 underlying)
  • Sale

    Common Stock

    2024-06-17$94.50/sh9,722$918,7290 total
  • Sale

    Common Stock

    2024-06-17$93.25/sh1,875$174,8440 total
  • Exercise/Conversion

    Common Stock

    2024-06-17$3.12/sh+5,625$17,5505,625 total
  • Exercise/Conversion

    Common Stock

    2024-06-17$6.25/sh+3,750$23,4383,750 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2024-06-173,7503,750 total
    Exercise: $6.25Exp: 2031-08-01Common Stock (3,750 underlying)
  • Exercise/Conversion

    Common Stock

    2024-06-17$9.58/sh+1,875$17,9631,875 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2024-06-175,6251,875 total
    Exercise: $3.12Exp: 2030-08-01Common Stock (5,625 underlying)
Footnotes (5)
  • [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.49 to $94.54, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.21 to $93.30, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  • [F3]Options granted on November 5, 2020 which vest in four equal annual installments commencing on August 1, 2021.
  • [F4]Options granted on January 25, 2022 which vest in four equal annual installments commencing on August 1, 2022.
  • [F5]Options granted on January 24, 2023 which vest in four equal annual installments commencing on January 24, 2024.

Documents

1 file
  • 4
    wk-form4_1718744421.xmlPrimary

    FORM 4